In vitro biosynthesis and chemical identification of UDP-N-acetyl-D-quinovosamine (UDP-D-QuiNAc) [Metabolism]

May 9th, 2014 by Li, T., Simonds, L., Kovrigin, E. L., Noel, K. D.

N-acetyl-D-quinovosamine (QuiNAc) occurs in the polysaccharide structures of many Gram-negative bacteria. In the biosynthesis of QuiNAc-containing polysaccharides, UDP-N-acetyl-D-quinovosamine is the hypothetical donor of the QuiNAc residue. Biosynthesis of UDP-QuiNAc has been proposed to occur by 4,6-dehydration of UDP-N-acetyl-D-glucosamine (UDP-GlcNAc) to UDP-2-acetamido-2,6-dideoxy-D-xylo-4-hexulose, followed by reduction of this 4-keto intermediate to UDP-QuiNAc. Several specific dehydratases are known to catalyze the first proposed step. A specific reductase for the last step has not been demonstrated in vitro, but previous mutant analysis suggested that Rhizobium etli gene wreQ might encode this reductase. Therefore, this gene was cloned and expressed in E. coli, and the resulting His6-tagged WreQ protein was purified. It was tested for 4-reductase activity by adding it and NAD(P)H to reaction mixtures in which 4,6-dehydratase WbpM had acted on the precursor substrate UDP-GlcNAc. Thin layer chromatography of the nucleotide-sugars in the mixture at various stages of the reaction showed that WbpM converted UDP-GlcNAc completely to what was shown to be its 4-keto-6-deoxy derivative by NMR and that addition of WreQ and NADH led to formation of a third compound. Combined gas chromatography-mass spectrometry analysis of acid hydrolysates of the final reaction mixture showed that a quinovosamine moiety had been synthesized after WreQ addition. The two-step reaction progress also was monitored in real-time by NMR. The final UDP-sugar product after WreQ addition was purified and determined to be UDP-D-QuiNAc by 1D and 2D- NMR experiments. These results confirmed that WreQ has UDP-2-acetamido-2,6-dideoxy-D-xylo-4-hexulose 4-reductase activity, completing a pathway for UDP-D-QuiNAc synthesis in vitro.